EICHOR
● Active Not Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition: Acute Liver Failure · Fulminant Hepatic Failure · Hepatic Encephalopathy · Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
About this study
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (17)
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| Lucile Packard Children's Hospital | Palo Alto, California, United States | — |
| Rady Children's Hospital | San Diego, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | — |
| Riley Hospital for Children | Indianapolis, Indiana, United States | — |
| Children's Hospital Boston | Boston, Massachusetts, United States | — |
| The Children's Mercy Hospital | Kansas City, Missouri, United States | — |
| St. Louis Children's Hospital | St Louis, Missouri, United States | — |
| NYP Morgan Stanley Children's Hospital | New York, New York, United States | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | — |
| The Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | — |
+ 5 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04862221